EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

Gabrielle Fröberg, Florian P Maurer, Erja Chryssanthou, Louise Fernström, Hanaa Benmansour, Samira Boarbi, Anne Torunn Mengshoel, Peter Michael Keller, Miguel Viveiros, Diana Machado, Margaret M Fitzgibbon, Simone Mok und 15 weitere

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.02.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Gabrielle Fröberg und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Infectious Diseases, Department of Medicine Solna…. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Mycobacterium avium-intracellulare Infection, Mycobacterium tuberculosis, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: For non-tuberculous mycobacteria (NTM), minimum inhibitory concentration (MIC) distributions of wild-type isolates have not been systematically evaluated despite their importance for establishing antimicrobial susceptibility testing (AST) breakpoints. METHODS: We gathered MIC distributions for drugs used against the Mycobacterium avium complex (MAC) and Mycobacterium abscessus (MAB) obtained by commercial broth microdilution (SLOMYCOI and RAPMYCOI) from 12 laboratories. Epidemiological cut-off values (ECOFFs) and tentative ECOFFs (TECOFFs) were determined by EUCAST methodology including quality control (QC) strains. RESULTS: The clarithromycin ECOFF was 16 mg/L for M. avium (n = 1271) whereas TECOFFs were 8 mg/L for M. intracellulare (n = 415) and 1 mg/L for MAB (n = 1014) confirmed by analysing MAB subspecies without inducible macrolide resistance (n = 235). For amikacin, the ECOFFs were 64 mg/L for MAC and MAB. For moxifloxacin, the WT spanned >8 mg/L for both MAC and MAB. For linezolid, the ECOFF and TECOFF were 64 mg/L for M. avium and M. intracellulare, respectively. Current CLSI breakpoints for amikacin (16 mg/L), moxifloxacin (1 mg/L) and linezolid (8 mg/L) divided the corresponding WT distributions. For QC M. avium and M. peregrinum, ≥95% of MIC values were well within recommended QC ranges. CONCLUSION: As a first step towards clinical breakpoints for NTM, (T)ECOFFs were defined for several antimicrobials against MAC and MAB. Broad wild-type MIC distributions indicate a need for further method refinement which is now under development within the EUCAST subcommittee for anti-mycobacterial drug susceptibility testing. In addition, we showed that several CLSI NTM breakpoints are not consistent in relation to the (T)ECOFFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusMycobacterium avium-intracellulare InfectionMycobacterium tuberculosisMycobacterium Infections, NontuberculousHumansMycobacterium avium ComplexAnti-Bacterial AgentsNontuberculous MycobacteriaAmikacinMoxifloxacinLinezolidMicrobial Sensitivity TestsDrug Resistance, BacterialMacrolidesMycobacterium avium

Stichwörter der Autor:innen

Broth microdilutionDrug susceptibility testingECOFFMycobacteriumMycobacterium abscessusMycobacterium aviumNon-tuberculous mycobacteria

Substanzen

Anti-Bacterial AgentsAmikacinMoxifloxacinLinezolidMacrolides

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Internal Medicine, Lycksele Hospital, Lycksele, Sweden.
  • AP-HP, GHU Nord, Service de Mycobactériologie Spécialisée et de référence, laboratoire associé au Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Université Pari…
  • National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium.

Zitieren

APA

Fröberg, G., Maurer, F. P., Chryssanthou, E., Fernström, L., Benmansour, H., Boarbi, S., Mengshoel, A. T., Keller, P. M., Viveiros, M., Machado, D., Fitzgibbon, M. M., Mok, S., Werngren, J., Cirillo, D. M., Alcaide, F., Hyyryläinen, H. L., Aubry, A., Andres, S., Nadarajan, D., …, & EUCAST AMST and ESCMYC study groups (2023). Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.02.007

Vancouver

Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, et al. Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.02.007

BibTeX
@article{Frberg2023,
  author = {Fröberg, Gabrielle and Maurer, Florian P and Chryssanthou, Erja and Fernström, Louise and Benmansour, Hanaa and Boarbi, Samira and Mengshoel, Anne Torunn and Keller, Peter Michael and Viveiros, Miguel and Machado, Diana and Fitzgibbon, Margaret M and Mok, Simone and Werngren, Jim and Cirillo, Daniela Maria and Alcaide, Fernando and Hyyryläinen, Hanne-Leena and Aubry, Alexandra and Andres, Sönke and Nadarajan, Darshaalini and Svensson, Erik and Turnidge, John and Giske, Christian G and Kahlmeter, Gunnar and Cambau, Emmanuelle and van Ingen, Jakko and Schön, Thomas and EUCAST AMST and ESCMYC study groups, EUCAST AMST and ESCMYC study groups},
  title = {Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.02.007}
}
Kostenlos starten →